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Error dependent on renal function when monoexponential 
equation assumed 
Serum clearances of 1251-iothalamate and 1311-0-iodohippurate 
An example from the literature has been used to demonstrate errors involved in 
calculating drug clearance by inappropriate use of the apparent drug distribution volume 
V dext. The V dext is always an overestimate of the true volume of distribution in a 
multicompartment system, and the degree of overestimation in using it to calculate 
clearance for such a system will increase as renal function increases. Drug dosages 
calculated on the basis of overestimated clearance values may give rise to overdosage in 
normal individuals, or therapeutic failure in severely uremic patients. Problems 
associated with the use of an oversimplified pharmacokinetic model for clearance 
calculations are discussed, together with the concept of model-independent calculations. 
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Drug clearance (sometimes called "meta-
bolic clearance rate") is an important pharma-
cokinetic parameter useful in the evaluation of 
hepatic or renal function and adjustment of drug 
dosage regimens. It was first defined in 1956 by 
Hoenig and Schiick3 as the ratio of intrave-
nous dose to the area under the plasma 
concentration-time curve from zero to infinity, 
which has since been used to calculate the renal 
clearance of 125I-iothalamate, I the plasma clear-
ance of penicillin, 10 and the metabolic clearance 
rates of cortisol5 and prednisolone. 4 
Although this formula is not based on the 
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assumption of a pharmacokinetic model, 
model-specific formulas have been derived. For 
the one-compartment open model, clearance is 
simplified to the product of Al (the apparent 
first-order elimination rate constant) and V dapp * 
(the apparent volume of distribution). Clear-
ance for all other linear compartment models is 
equal to the product of Al and V darea (the vol-
ume of distribution at any time during the ter-
minal log-linear phase of drug elimination). 
(See Appendix, Equations 1 to 11 for deriva-
tions. ) 
Unfortunately, too many investigators inap-
propriately assume a one-compartment open 
model by using V dapp or V dext to calculate clear-
ance for data which are perhaps better fitted to a 
*v dspp is often used interchangeably with V dex', the extrapolated 
volume of distribution. 
609 
610 MacKichan et al. Clinical Pharmacology 
and Therapeutics 
Table I. Summary of average pharmacokinetic parameters for 0[H 1311 
Parameter Group I Group 2 Group 3 
CCl* (ml/min) 77.8 (39.7)t (50)* 47.6(35.7)(17) 18.5 (30.5) (6) 
Al (hr- I) 0.46 (41.9) (53) 0.33 (32.8) (19) 0.22 (32.7) (7) 
V darea (L) 60.6 (71. 9) (53) 39.1 (68.1) (19) 31.8 (34.2) (7) 
Vdext (L) 112 (89.1) (53) 61.4(99.3) (19) 37.0 (40.3) (7) 
V dext . AI 691 (51.5) (53) 272 (48.3) (19) 134 (54.7) (7) 
(m1lmin) 
V darea • AI 399 (47.3) (53) 188 (39.1) (19) 114 (47.1) (7) 
(ml/min) 
Percentage 74.7 (85.1) (53) 42.7 (82.4) (19) 14.8 (67.4) (7) 
error (%) 
*Creatinine clearance. 
. . . standard deviation 
tCoefficlent ofvanatlon (%): mean x 100. 
tNumber of determinations. 
Table II. Summary of average pharmacokinetic parameters for IOp25[ 
Parameter Group 1 
CCI (m1lmin) 80.0 (37.1)(45) 
Al (hr-I ) 0.25 (34.6) (46) 
V darea (L) 22.6 (21.7)(46) 
V dext (L) 26.1 (27.7)(46) 
V dext • Al 110 (40.1) (46) 
(m1lmin) 
V darea . AI 95.5 (37.1) (46) 
(ml/min) 
Percentage 14.3 (58.9) (46) 
error (%) 
more complex model. Clearances have been 
calculated for intravenous antipyrine and tol-
butamide8 as well as oral pentobarbitaF using 
the formula specific for the one-compartment 
open model (Equation 7). Other workers,6. 11. 12 
however, have shown that the data of these 
drugs are actually best described by a bioexpo-
nential equation and not by a monoexponen-
tial equation as the one-compartment model 
requires. 
Although it has been shown that error is in-
troduced when parameter estimates for mul-
ticompartment data are calculated by equations 
for the simple one-compartment system,9. 14 the 
magnitude and significance of this error have 
not been demonstrated. This study was under-
taken to quantitate the degree of error intro-
duced when drug clearance is calculated by the 
use of an incorrect pharmacokinetic model. By 
purposely assuming a one-compartment model 
Group 2 Group 3 
45.1 (38.8) (19) 18.8 (50.9) (8) 
0.15 (39.2) (21) 0.07 (50.7) (8) 
19.6 (37.4) (21) 21.7 (19.0) (8) 
21.0 (36.9) (21) 22.3 (18.7) (8) 
49.4 (42.2) (21 26.8 (57.0) (8) 
45.8 (39.7) (21) 25.9 (57.1) (8) 
7.19 (90.6) (21) 3.33 (56.6) (8) 
to calculate serum clearance for data described 
by a biexponential equation, we show not only 
the degree of error in the calculated clearance 
values, but, more importantly, the dependence 
of percentage error on renal function. The im-
portance of model-independent pharmacoki-
netic parameter calculations is discussed. 
Methods 
The pharmacokinetic data of 1311_0_ 
iodohippurate (OIH I311) and 1251-iothalamate 
(IOp251) from Welling and co-workers l5 were 
used in this investigation. In the original study, 
male patients were divided into three groups on 
the basis of renal function: group 1 (53 patients) 
was designated as normal with serum cre-
atinines equal to or less than 1.5 mg per 100 
ml; group 2 (21 patients), with ~erum cre-
atinines between 1.6 and 2.5 mg per 100 ml, 
was designated moderately uremic; and group 3 
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Fig. 1. Relationship of percentage error in clearance calculation to endogenous creatinine clearance 
for OIHI31I (A) and IOTI251 (B), all patients. The dashed lines represent the least squares lines of 
best fit: r = 0.28 (OIH I31I) and 0.56 (lOTI25I). 
(9 patients) was designated severely uremic 
with serum creatinines greater than 2.5 mg per 
100 m!. Each patient received 10 to 20 j.LCi of 
OlH I311 and IOP251 as indicators of renal func-
tion by rapid intravenous injection. Serum sam-
ples were obtained immediately before and at 
0.25, 0.5, 1.0, 2.0, 4.0, and 8.0 hr following 
injection. In the present study the coefficients 
and exponents of the biexponential equation de-
scribing the serum concentration-time curve 
(Equation 3) were obtained enabling the calcu-
lation of V dext and V darea for each patient using 
Equations 8 and 10. Serum clearances were cal-
culated two ways for each patient (Equations 7 
and 9), and the percentage difference between 
the values was found by 
(V dext . AI) - (V darea . AI) x 100 
(V darea . AI) 
where V darea • Al is the true serum clearance 
and Al is the smallest rate constant. The means, 
standard deviations, and coefficients of varia-
tion were calculated for all parameters, and 
linear regression analysis was done to relate 
percentage error in clearance calculation to the 
endogenous creatinine clearance. 
Results 
The mean pharmacokinetic parameters on 
OlH I311 and IOTI251 are given in Tables I and 
II. Included in the tables are the endogenous 
creatinine clearance and the percentage error 
introduced by drug clearance calculations based 
on the assumption of a one-compartment mod-
el. With both drugs, the mean percentage er-
ror was large in normal patients, less in pa-
tients with moderate uremia, and quite small in 
severely uremic individuals. The relationship of 
percentage error in calculation of drug clear-
ances to the endogenous creatinine clearance is 
illustrated in Fig. 1. Fig. 2 graphically depicts 
the effect of renal impairment, represented by 
the three patient groups, on the mean percent-
age error. The difference among the mean per-
centage errors for the three groups was sig-
nificant (p < 0.005) for both drugs, using 
the Kruskal-Wallis H test. 2 
Discussion 
Wagner and Northaml4 have shown that the 
apparent or extrapolated volume of distribution 
in a multi compartment open system is always 
an overestimate of the true total volume. It fol-
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Fig. 2. Effect of degree of renal impairment on mean percentage error in clearance calculation for 
OIH131J (A) and IOT1251 (B). Group I, normal; Group 2, moderately uremic; Group 3, severely 
uremic. 
lows that clearances calculated using V dext for 
data described by a biexponential equation will 
also be overestimated as verified by our results, 
where the mean overestimation for OIH131I was 
as high as 75%. Equation 13 in the appendix 
shows that the degree of error introduced de-
pends on the relative values of the coefficients 
and exponents of the biexponential equation de-
scribing the system, or it depends on how 
"two-compartment" the system is. In renal 
failure, the elimination rate constant, A\> is 
smaller, thus decreasing the ratio indicative of 
degree of error. This is demonstrated in Figs. 1 
and 2 where the percentage error is seen to de-
crease as renal function decreases. 
The clinical importance of this error cannot 
be overlooked. Because the magnitude of error 
may be large, and because it depends on the 
degree of renal function, the use of the one-
compartment formula for data fitted by a biex-
ponential equation may be unreliable, espe-
cially for drugs excreted primarily by the kid-
ney. As overestimation of clearance increases 
with increasing renal function, the use of V dext 
could give rise to drug overdoses in normal in-
dividuals. Alternatively, if the calculated dose 
produces a required therapeutic effect in nor-
mals, dose adjustment in uremic patients based 
on clearance values using V dext may lead to 
therapeutic failure due to disproportionate dose 
reduction. If serum or plasma clearances are 
used to evaluate renal function, as for OIH131I 
and IOP25, overestimation of the clearances 
will indicate that the renal function is better 
than it actually is. In general, because plasma or 
serum clearance is often used to adjust drug 
dosage and evaluate renal function, a large de-
gree of error in its calculation may adversely 
affect a patient's therapeutic regimen. 
Because the assumption of an incorrect 
pharmacokinetic model for a set of blood con-
centration vs time data may lead to a high de-
gree of error in clearance calculations, an alter-
native method for these calculations might be 
used. Due to the uncertainty of the correctness 
of a particular pharmacokinetic model, another 
approach to the problem would be one that is 
"model-independent." Instead of assuming a 
model and basing parameter calculations on that 
model, one can find the polyexponential equa-
tion that best fits the experimental data and cal-
culate clearance directly from the coefficients 
and exponents of that equation. 13 Errors associ-
ated with assumption of an incorrect pharma-
cokinetic model may be eliminated in this 
manner. 
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The general polyexponential equation describing a plasma or serum concentration versus time curve is 
CIV = ~ Cje-hjl 
where CIV is the concentration in plasma or serum following bolus intravenous injection. 
The monoexponential equation 
describes the classic one-compartment open model, while the biexponential equation 
CIV = C1e-h21 + C2e-h21 
describes the classic two-compartment open model. 
[1] 
[2] 
[3] 
The general equation for finding the area under the concentration-time curve from zero to infinity is simply the 
sum of the ratio of coefficients to their exponents: 
C1 
AUCo--.oo = ~ Ai 
which for a one-compartment open model is equal to 
and for a two-compartment open model equals 
[4] 
[5] 
[6] 
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Thus, the clearances for each model, defined as the ratio of the intravenous dose to the area under the concen-
tration-time curve from zero to infinity, are given by Equations 7 and 9. 
One compartment model: 
Multicompartment model: 
where 
Dose IV 
Cl = AUC()->oo 
Dose IV 
C./A. V dext . A. 
Dose!V 
where V dext = ~ . 
DoseIV 
Cl = AUC()->oo 
DoseIV 
= --C- = Vdarea . Al 
I--.! 
Ai 
Dose!V 
V darea = AlI (CI/Ai) 
and for data described by a biexponential equation: 
[7] 
[8] 
[9] 
[10] 
[ 11] 
One can see that the clearance formula for a one-compartment model cannot be applied to data described by 
anything except a monoexponential equation. If a one-compartment model is assumed for polyexponential data, 
the ratio of clearance calculated by (V dext • AI) to the true clearance (V darea . AI) is given by: 
V dext . A I _ V dext _ 
V darea' Al - V darea -
DoseIVI C I 
Doselv 
Al (I CJ Ai) 
[12] 
When a one-compartment model is erroneously assumed for data described by a biexponential equation, this 
ratio is equal to: 
DoseIV/CI 
Dose!V _ I + C2 Al . 
Al (CI/AI + C2/A2) CI A2 
[ 13] 
Thus, it can be seen that the error in calculation of clearance by assumption of a one-compartment open model 
depends on the values of both coefficients CI and C2 , and both rate constants, Al and 1..2 , 
